Save Money On Your Rx
Gut hormone blocks brain cell formation and is linked to Parkinson's dementia
on October 22, 2020 at 10:38 pm
A gut hormone, ghrelin, is a key regulator of new nerve cells in the adult brain, a research team has discovered. It could help pave the way for new drugs to treat dementia in patients with Parkinson's Disease.
Diagnosing Parkinson's disease with skin samples could lead to earlier detection
on October 21, 2020 at 3:23 pm
New research shows a simple skin test can accurately identify Parkinson's disease, which could lead to earlier detection of the disease and better outcomes for patients. Currently, Parkinson's disease is diagnosed by clinical signs and symptoms but only definitively diagnosed at autopsy. The researchers conducted a blinded study of 50 skin samples using an assay originally designed to detect mad cow disease.
New study highlights links between inflammation and Parkinson's disease
on October 14, 2020 at 3:46 pm
Researchers established an association between inflammation and specific genetic mutations in Parkinson's patients. The study highlights two biomarkers that could be used to assess Parkinson's disease state and progression. The results also suggest that targeting the immune system with anti-inflammatory medication holds the potential to influence the disease course, at least in a subset of patients.
People with Parkinson's disease have a higher risk of dying from COVID-19
on October 1, 2020 at 5:32 pm
A new database analysis of approximately 80,000 patients shows that people with Parkinson's disease (PD) have a 30 percent higher death rate from COVID-19 than people without the neurodegenerative condition.
First 'pathoconnectome' could point toward new treatments for neurodegenerative diseases
on September 29, 2020 at 4:36 pm
Scientists have achieved another first in the field of connectomics, which studies the synaptic connections between neurons. The lab has produced the first pathoconnectome, showing how eye disease alters retinal circuitry.